These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Rapamycin Combined with Immature Dendritic Cells Attenuates Obliterative Bronchiolitis in Trachea Allograft Rats by Regulating the Balance of Regulatory and Effector T Cells. Dong M; Wang X; Liu J; Zhao YX; Chen XL; Li KQ; Li G Int Arch Allergy Immunol; 2015; 167(3):177-85. PubMed ID: 26302996 [TBL] [Abstract][Full Text] [Related]
24. Apoptosis of the Tracheal Epithelium Can Increase the Number of Recipient Bone Marrow-Derived Myofibroblasts in Allografts and Exacerbate Obliterative Bronchiolitis After Tracheal Transplantation in Mice. Wang C; Xia T; Jiang K; Qiao X; Zhang X; Li J; Wang J; Nie J Transplantation; 2016 Sep; 100(9):1880-8. PubMed ID: 27163540 [TBL] [Abstract][Full Text] [Related]
25. A dose-dependent inhibitory effect of cyclosporine A on obliterative bronchiolitis of rat tracheal allografts. Koskinen PK; Kallio EA; Krebs R; Lemström KB Am J Respir Crit Care Med; 1997 Jan; 155(1):303-12. PubMed ID: 9001329 [TBL] [Abstract][Full Text] [Related]
26. Blockade of complement inhibits obliterative bronchiolitis in rat tracheal allografts. Kallio EA; Lemström KB; Häyry PJ; Ryan US; Koskinen PK Am J Respir Crit Care Med; 2000 Apr; 161(4 Pt 1):1332-9. PubMed ID: 10764331 [TBL] [Abstract][Full Text] [Related]
27. Mesenchymal stem cells reprogram host macrophages to attenuate obliterative bronchiolitis in murine orthotopic tracheal transplantation. Guo Z; Zhou X; Li J; Meng Q; Cao H; Kang L; Ni Y; Fan H; Liu Z Int Immunopharmacol; 2013 Apr; 15(4):726-34. PubMed ID: 23499643 [TBL] [Abstract][Full Text] [Related]
28. Repeated systemic administration of adipose tissue-derived mesenchymal stem cells prevents tracheal obliteration in a murine model of bronchiolitis obliterans. Lorenzi W; Gonçalves FDC; Schneider N; Silva ÉF; Visioli F; Paz AH; Saueressig MG Biotechnol Lett; 2017 Aug; 39(8):1269-1277. PubMed ID: 28528427 [TBL] [Abstract][Full Text] [Related]
29. Reproduction of the obliterative bronchiolitis lesion after heterotopic transplantation of mouse airways. Hertz MI; Jessurun J; King MB; Savik SK; Murray JJ Am J Pathol; 1993 Jun; 142(6):1945-51. PubMed ID: 8506960 [TBL] [Abstract][Full Text] [Related]
30. IL-25 regulates the polarization of macrophages and attenuates obliterative bronchiolitis in murine trachea transplantation models. Liu J; Zhou X; Zhan Z; Meng Q; Han Y; Shi Q; Tang J; Li J; Fan H; Liu Z Int Immunopharmacol; 2015 Apr; 25(2):383-92. PubMed ID: 25681538 [TBL] [Abstract][Full Text] [Related]
31. Growth factor upregulation during obliterative bronchiolitis in the mouse model. Aris RM; Walsh S; Chalermskulrat W; Hathwar V; Neuringer IP Am J Respir Crit Care Med; 2002 Aug; 166(3):417-22. PubMed ID: 12153981 [TBL] [Abstract][Full Text] [Related]
32. Anti-allergic agent tranilast decreases development of obliterative airway disease in rat model of heterotopic tracheal transplantation. Okada Y; Matsumura Y; Shimada K; Sado T; Oyaizu T; Sugawara T; Matsuda Y; Hoshikawa Y; Takahashi H; Sato M; Kondo T J Heart Lung Transplant; 2004 Dec; 23(12):1392-5. PubMed ID: 15607669 [TBL] [Abstract][Full Text] [Related]
33. Role of nitric oxide in experimental obliterative bronchiolitis (chronic rejection) in the rat. Kallio EA; Koskinen PK; Aavik E; Vaali K; Lemstöm KB J Clin Invest; 1997 Dec; 100(12):2984-94. PubMed ID: 9399944 [TBL] [Abstract][Full Text] [Related]
34. FK778 and tacrolimus prevent the development of obliterative airway disease after heterotopic rat tracheal transplantation. Deuse T; Schrepfer S; Koch-Nolte F; Haddad M; Schwedhelm E; Böger R; Schäfer H; Detter C; Reichenspurner H J Heart Lung Transplant; 2005 Nov; 24(11):1844-54. PubMed ID: 16297791 [TBL] [Abstract][Full Text] [Related]
35. Reduction of recipient macrophages by gadolinium chloride prevents development of obliterative airway disease in a rat model of heterotopic tracheal transplantation. Oyaizu T; Okada Y; Shoji W; Matsumura Y; Shimada K; Sado T; Sato M; Kondo T Transplantation; 2003 Oct; 76(8):1214-20. PubMed ID: 14578756 [TBL] [Abstract][Full Text] [Related]
36. Innate and adaptive immune responses in obliterative airway disease in rat tracheal allografts. Ropponen JO; Syrjälä SO; Krebs R; Nykänen A; Tikkanen JM; Lemström KB J Heart Lung Transplant; 2011 Jun; 30(6):707-16. PubMed ID: 21411341 [TBL] [Abstract][Full Text] [Related]
37. Invited commentary. van der Kaaij NP; Bogers AJ Ann Thorac Surg; 2006 Sep; 82(3):1050-1. PubMed ID: 16928533 [No Abstract] [Full Text] [Related]
38. Tacrolimus treatment effectively inhibits progression of obliterative airway disease even at later stages of disease development. Hollmén M; Tikkanen JM; Nykänen AI; Koskinen PK; Lemström KB J Heart Lung Transplant; 2008 Aug; 27(8):856-64. PubMed ID: 18656798 [TBL] [Abstract][Full Text] [Related]
39. Suppression of bronchiolitis obliterans in allogeneic rat lung transplantation--effectiveness of everolimus. von Suesskind-Schwendi M; Brunner E; Hirt SW; Diez C; Ruemmele P; Puehler T; Schmid C; Lehle K Exp Toxicol Pathol; 2013 May; 65(4):383-9. PubMed ID: 22284335 [TBL] [Abstract][Full Text] [Related]
40. Obliterative bronchiolitis in haematopoietic stem cell transplantation: can it be treated? Bryant DH Eur Respir J; 2005 Mar; 25(3):402-4. PubMed ID: 15738280 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]